Subscribe: Biotechnology
Added By: Feedage Forager Feedage Grade A rated
Language: English
announced  company  global  oct prnewswire  oct  patients  pharmaceutical  prnewswire  results  therapeutics  today announced  today  und 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Biotechnology

PR Newswire: Biotechnology

Press Releases from PR Newswire about Biotechnology

Published: Tue, 25 Oct 2016 18:54:58 EDT

Last Build Date: Tue, 25 Oct 2016 17:10:00 EDT


Global $2.2 Billion Microbiome Therapeutics and Diagnostics Pipeline Analysis and Market Outlook 2016-2025 - Research and Markets

Tue, 25 Oct 2016 17:10:00 EDT

(image) DUBLIN, October 25, 2016 /PRNewswire/ -- Research and Markets has announced the addition of the "Microbiome Therapeutics and Diagnostics: Pipeline Analysis and Market Outlook" report to their offering. By 2025, the human microbiome market could be worth $2.2 billion Top...

Media Files:

NASA Television to Air Return of Three Space Station Crew Members

Tue, 25 Oct 2016 17:09:00 EDT

(image) WASHINGTON, Oct. 25, 2016 /PRNewswire-USNewswire/ -- Three crew members on the International Space Station are scheduled to depart the orbital outpost Saturday, Oct. 29, with coverage of activities beginning the day before on NASA Television and the agency's website. Expedition 49...

Media Files:

Roka Bioscience to Present at the Sidoti & Company Fall 2016 Emerging Growth Convention

Tue, 25 Oct 2016 16:30:00 EDT

(image) WARREN, N.J., Oct. 25, 2016 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced today that Mary Duseau and Lars Boesgaard will be presenting on behalf of...

Media Files:

Regulus to Release Third Quarter Financial Results on November 1, 2016

Tue, 25 Oct 2016 16:15:00 EDT

(image) LA JOLLA, Calif., Oct. 25, 2016 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced it will release third quarter financial results on Tuesday, November 1,...

Media Files:

Edwards Lifesciences Reports Third Quarter Results

Tue, 25 Oct 2016 16:15:00 EDT

(image) IRVINE, Calif., Oct. 25, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended September 30, 2016. Third Quart...

Media Files:

Mayor, Roche chairman lead Indianapolis site dedication

Tue, 25 Oct 2016 15:30:00 EDT

(image) INDIANAPOLIS, Oct. 25, 2016 /PRNewswire/ -- Today, Indianapolis Mayor Joe Hogsett joined Chairman of the Roche Group Christoph Franz, global and local Roche leaders, and employees to lead a dedication ceremony at the Roche Diagnostics North American headquarters. The ceremony...

Media Files:

BIO-Europe® 2016 bringt vom 7. bis 9. November führende Unternehmen der globalen Life-Sciences-Branche nach Köln

Tue, 25 Oct 2016 15:24:00 EDT

KARLSBAD, Kalifornien und KÖLN, Deutschland, October 25, 2016 /PRNewswire/ -- Wie können wir im Verlauf des menschlichen Lebenszyklus gesund bleiben? Welche Rolle werden neue Zell- und Gentherapien bei der Erreichung dieses Ziels spielen? Wann und zu welchem Preis werden die neuen...

Stavros Vizirgianakis, Interim Misonix CEO, Invests $4 Million in Misonix Common Stock

Tue, 25 Oct 2016 15:00:00 EDT

(image) FARMINGDALE, N.Y., Oct. 25, 2016 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, neurosurgery, wound debridement, skull based surgery, laparoscopic...

Media Files:

Direct To Consumer Campaigns For Pfizer's Xeljanz, Abbvie's Humira, And Amgen's Enbrel The Most Influential With RA Patients

Tue, 25 Oct 2016 14:35:00 EDT

(image) CAMBRIDGE, Mass., Oct. 25, 2016 /PRNewswire/ -- Survey responses of nearly 100 US rheumatologists reveal that RA patients are significantly more influenced by the DTC campaigns of Xeljanz, Humira, and Enbrel than any other RA biologic.  Despite patient influence, US rheumatologists tend to...

Media Files:

Menarini-Silicon Biosystems und Swift Biosciences kündigen Zusammenarbeit bei Angebot von angepassten NGS-Technologien für Tumorzellenanalyse an

Tue, 25 Oct 2016 14:06:00 EDT

(image) Produkte sind optimiert für gezielte Resequenzierung und Exom-Sequenzierung von FFPE-Zellen BOLOGNA, Italien, 25. Oktober 2016 /PRNewswire/ -- Menarini-Silicon Biosystems Inc., ein Unternehmen zur Entwicklung und Herstellung von Technologien und Produkten, die der Erforschung der...

Media Files:

TheraCell and AlloSource Announce Issuance of Patent for Bone Fiber Technology

Tue, 25 Oct 2016 12:25:00 EDT

(image) NORTHRIDGE, Calif. and CENTENNIAL, Colo., Oct. 25, 2016 /PRNewswire-USNewswire/ -- TheraCell, a regenerative medicine company, today announced that the United States Patent and Trademark Office (USPTO) will issue TheraCell a patent for its demineralized bone fiber (DBF™) technology. The...

Media Files:

Continued Decline in Family Physicians Harmful to the Health of the United States: East Carolina University's Brody School of Medicine Answers the Vital Call

Tue, 25 Oct 2016 12:12:00 EDT

(image) GREENVILLE, N.C., Oct. 25, 2016 /PRNewswire/ -- For more than a decade, the medical industry has been sounding the alarm about the shortage of primary care physicians and how it may be harmful to the health of the United States, particularly for the underserved. According to the U.S....

Media Files:

Fimbrion y GSK desarrollarán innovadora terapia antibacteriana para infecciones de las vías urinarias

Tue, 25 Oct 2016 11:57:00 EDT

(image) ST. LOUIS, 25 de octubre de 2016 /PRNewswire-HISPANIC PR WIRE/ -- Fimbrion Therapeutics, Inc., una novel compañía de biotecnología centrada en desarrollar fármacos ahorradores de antibióticos, ha formalizado una colaboración con GlaxoSmithKline (GSK), una empresa global del cuidado de la...

Media Files:

Proposed Drastic Cuts In Reimbursement Rate Threatens Heart Transplant Patients

Tue, 25 Oct 2016 11:44:00 EDT

WASHINGTON, Oct. 25, 2016 /PRNewswire/ -- Heart transplant patients and doctors to explain consequences of reimbursement reduction proposed by CMS (Centers for Medicare and Medicaid Services) jeopardizing patient access to AlloMap Would cost taxpayers more money for heart...

Telesta Therapeutics Inc. shareholders approve plan of arrangement with ProMetic Life Sciences Inc.

Tue, 25 Oct 2016 11:23:00 EDT

(image) MONTREAL, Oct. 25, 2016 /PRNewswire/ - Telesta Therapeutics Inc. (TSX: TST; PNK: BNHLF) announced at a special meeting of shareholders held earlier today (the "Meeting") that Telesta shareholders voted in favour of the proposed transaction pursuant to which ProMetic Life Sciences Inc....

Media Files:

Cancer Patients and Cancer Facilities alike to benefit from new patented technology

Tue, 25 Oct 2016 10:15:00 EDT

(image) AVENTURA, Fla., Oct. 25, 2016 /PRNewswire/ -- RAD Technology Medical Systems (RAD) is adding two new patents to its portfolio of modular building technologies for cancer treatment facilities.  RAD has received patent approvals for their Temporary Radiotherapy Vault (TRV) from both the Japa...

Media Files:

PharmaJet® and Vaccibody collaborate on HPV vaccine development

Tue, 25 Oct 2016 10:05:00 EDT

(image) GOLDEN, Colo., Oct. 25, 2016 /PRNewswire/ -- PharmaJet today announced a collaboration with Vaccibody AS to provide needle-free injection technology for the study of a vaccine to eradicate HPV.  This disease is the main cause of cervical cancer affecting 530,000 women globally annually, an...

Media Files:

Fimbrion and GSK to Develop Novel Antibacterial Therapy for Urinary Tract Infections

Tue, 25 Oct 2016 09:45:00 EDT

(image) ST. LOUIS, Oct. 25, 2016 /PRNewswire/ -- Fimbrion Therapeutics, Inc., a start-up biotechnology company focused on developing antibiotic-sparing drugs, has entered into collaboration with GlaxoSmithKline (GSK), a science-led global healthcare company, to develop a small molecule drug for th...

Media Files:

Worldwide Clinical Trials to Unveil Results of Global Investigator Survey at CNS Summit

Tue, 25 Oct 2016 09:30:00 EDT

MORRISVILLE, North Carolina, October 25, 2016 /PRNewswire/ -- Worldwide Clinical Trials ( has announced findings from a recent global survey that evaluated preferences of investigators who participate in central nervous system (CNS) studies that employ rater...

Athenex and Beijing Sciecure Pharmaceutical announce binding agreement to launch and market five injectable pharmaceutical products in North America

Tue, 25 Oct 2016 09:20:00 EDT

(image) BUFFALO, N.Y. and HONG KONG, Oct. 25, 2016 /PRNewswire/ -- Athenex Pharmaceutical Division and Beijing Sciecure Pharmaceutical Co., Ltd., a specialty pharmaceutical company, today announced a binding agreement to launch and market 5 pharmaceutical products, all injectable, in the North...

Media Files: